Concepedia

James Maynard

JM

9

Publications

617

Citations

9

H-Index

2014

Active since

Affiliations

Clinical Trial and Consulting(Current)

St. Luke's Hospital

University of Arkansas for Medical Sciences

Jazz Pharmaceuticals (United States)

Research Network (United States)

James Maynard is an author at Clinical Trial and Consulting specializing in health sciences, exercise physiology, and electrophysiology.

Top concepts

Publications per year

2014–2023

9

Publications

9

Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial

Paula K. Schweitzer, Russell Rosenberg, Gary Zammit et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 305 citations · Full text

Solriamfetol for the Treatment of Excessive Sleepiness in OSA

Patrick Strollo, Jan Hedner, Nancy A. Collop et al. · CHEST Journal · 2018 · 80 citations · Full text

The Combination of Aroxybutynin and Atomoxetine in the Treatment of Obstructive Sleep Apnea (MARIPOSA): A Randomized Controlled Trial

Paula K. Schweitzer, Luigi Taranto‐Montemurro, Joseph Ojile et al. · American Journal of Respiratory and Critical Care Medicine · 2023 · 70 citations · Full text

A Pivotal Study to Validate the Performance of a Novel Wearable Sensor and System for Biometric Monitoring in Clinical and Remote Environments

Ellora Sen-Gupta, Donald E. Wright, James W. Caccese et al. · Digital Biomarkers · 2019 · 42 citations · Full text

Effects of Solriamfetol on Quality-of-Life Measures from a 12-Week Phase 3 Randomized Controlled Trial

Terri E. Weaver, Christopher L. Drake, Heike Beneš et al. · Annals of the American Thoracic Society · 2020 · 40 citations · Full text

Rows per page

1–5 of 9